Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04879849 |
Title | A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Takeda |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |